Prior Auth Required

81331 - E3A) (Eg, Prader-Willi Syndrome And/Or Angelman Syndrome), Methylation Analysis

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / ServiceE3A) (Eg, Prader-Willi Syndrome And/Or Angelman Syndrome), Methylation Analysis
Procedure / Service Description

dosage/deletion analysis (eg, carrier testing), includes SMN2 (survival of motor neuron 2, - 81330 Type A) Gene Analysis, Common Variants (Eg, R496L, L302P, Fsp330) Snrpn/Ube3A (Small Nuclear Ribonucleoprotein Polypeptide N And Ubiquitin Protein Ligase 81331 E3A) (Eg, Prader-Willi Syndrome And/Or Angelman Syndrome), Methylation Analysis SERPINA1 (serpin peptidase inhibitor, clade A, alpha-1 antiproteinase, antitrypsin, member 1) 81332 (eg, alpha-1-antitrypsin deficiency), gene analysis, common variants (eg, *S and *Z)

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.